Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,241 total articles
PG&E (PCG) has moved from a 52-week low of $12.97 to a fresh 52-week high of $18.38, and the stock looks set to climb further as fundamentals improve and regulatory support materializes. Valuation is reasonable at roughly 15x earnings and 1.2x book, while multiple catalysts - including a DOE loan guarantee, activist interest, and accelerating elect…
Huntington Ingalls (HII) has lagged some peers in rerating, but recent program wins, robust free cash flow, and a cleaner balance sheet point to a constructive trade. I am upgrading HII to a long trade at $418.25 with a $475 target and a $380 stop, horizon 180 trading days. The risk/reward is attractive given a $16.4B market cap, $794M annual free …
Micron is trading near $400 after a year of dramatic DRAM/NAND repricing and accelerating revenue. Institutional allocators are rotating in, earnings momentum is visible, and balance-sheet metrics support risk-taking. This trade targets continued DDR5-driven pricing power and share gains into 2026 while protecting capital with a strict stop.
Axalta delivered solid operational metrics, including a record adjusted EBITDA quarter, but the stock has failed to rally. Valuation is middling (P/E ~19.6, EV/EBITDA ~9.2) while leverage (debt/equity 1.36) and a thin catalyst set leave limited upside. We recommend a tactical short for the mid term (45 trading days) with strict risk controls.
Microsoft looks priced for disappointment while Azure momentum may be reaccelerating. Technicals show oversold conditions (RSI ~31) and heavy short activity; fundamentals still strong with a ~$2.95T market cap, ~25x P/E and $77B free cash flow. This trade targets a mid-term rebound if cloud bookings/AI demand re-accelerate.
Adobe is a cash-generative software giant trading at a $107B market cap, but weakening technicals, elevated valuation multiples versus growth expectations, and a sector-wide 'SaaSpocalypse' narrative create a near-term setup for a valuation check. We lay out a swing (45 trading days) short: entry $260.48, stop $280.00, target $230.00, with explicit…
S&P Global (SPGI) has been caught in a sector-wide 'AI-phobia' selloff that looks disconnected from fundamentals. The company still generates roughly $5.46B of free cash flow, trades at a reasonable P/E near 28, and yields about 0.9%. Technicals are deeply oversold (RSI ~26) and short interest has been elevated—conditions that can accelerate a mean…
Lumentum (LITE) sits squarely at the intersection of photonics and data-center scale AI. The stock has run hard, but structural demand for optical interconnects and a thin supply pipeline make Lumentum a tactical long with defined risk controls. This trade idea lays out an entry at $580.00, stop at $520.00 and a primary target of $800.00 over a lon…
Dave & Buster's (PLAY) is executing a 'back to basics' turnaround under new leadership. The stock trades at $15.74 with an enterprise value to EBITDA of 5.2 and market cap of ~$546M. A disciplined entry at $15.50 with a $13 stop and $25 target offers asymmetric risk/reward if management stabilizes comps and margins.
Arista reported stronger-than-expected Q4 results and gave confident Q1 revenue guidance. With AI networking demand still accelerating and cloud customers shifting toward Ethernet, revenue growth should re-accelerate later in 2026. The trade here is a long position sized to a plan with a clear entry, stop and target tied to margin recovery and orde…
Aquestive plunged on an FDA letter that identified deficiencies in the Anaphylm NDA but confirmed review remains ongoing. The underlying biology, patents, and a recent funding line argue the program is viable; the stock now trades like a binary gamble. This trade idea lays out a mid-term, event-driven long with entry, stop, and target levels, and a…
Safran's aftermarket business is accelerating, margins are improving, and momentum indicators are bullish. With elevated short interest and constructive technicals, we upgrade to Strong Buy and recommend entering at $404.11 with a $480 target and a $368 stop. We expect the trade to play out over the next 180 trading days as recurring services and m…
Danaos (DAC) looks cheap on headline multiples and has a $4.3B contracted backlog and strong charter coverage for 2026. Management's $90 per-share special dividend and an announced stake in the Alaska LNG project complicate the capital-allocation picture. This trade favors a disciplined long exposure that expects the market to look past a temporary…
Build-A-Bear (BBW) has shifted from turnaround to growth, delivering record revenue and stronger margins while sitting on a clean balance sheet and healthy free cash flow. With a market cap near $660M, PE around 11x, and an oversold technical backdrop, I like a controlled long swing trade that targets continued franchise rollouts, commercial/licens…
Fastly ripped higher after a clean Q4 beat and bullish 2026 guide. The market is re-pricing edge infrastructure as an AI growth story; with strong volume, a shrinking float hangover and clear upside to former resistance, Fastly looks like a high-conviction swing trade. Entry, stop and target provided with a 45-trading-day plan and explicit risk con…
<p>AppLovin (APP) has come off its highs but still carries premium multiples. That said, its free cash flow generation and AI-driven ad stack give it a structural advantage that justifies a tactical long entry on this pullback. We use a simple 'Rule of 150' EV/FCF threshold as a sanity check: APP's EV-to-FCF (~40x) comfortably clears that bar. Pair…
Nvidia's leadership in GPUs and data-center networking, combined with massive free cash flow and low leverage, make the stock a compelling tactical long. Technicals are constructive, short-interest is modest relative to liquidity, and upcoming developer and earnings catalysts offer asymmetric upside. Trade plan offers defined entry, target and stop…
Alibaba shares sit on near-term technical support around $154.76 heading into the company's 02/19/2026 earnings. Fundamentals show a large-cap, profitable platform with a $377.3B market cap, P/E of 20.8 and accelerating AI-related capital spending and strategic moves (T-Head spin-off) that could re-rate the stock if execution and cloud momentum rem…
PayPal trades like a mature payments incumbent that briefly forgot how to trade like one. At roughly $41, shares offer exposure to a large digital-payments network at about 7x earnings, positive free cash flow and a balance sheet that can support optionality. The trade: buy into the oversold dip, keep a tight stop below the recent support band, and…
Genpact has been executing a transformation toward higher-value digital services while generating robust cash flow and attractive returns on capital. At $37.62 the stock offers a favorable risk/reward: steady free cash flow ($649M), EPS of $3.24 and a P/E of ~12 imply re-rating potential if growth and margin leverage continue. Technicals show short…
Novo Nordisk (NVO) has been punished by accelerating competition and pricing pressure in the GLP-1/obesity market. At $49.20 the stock prices in a deep growth scare and a guidance cut, but the business still generates meaningful cash flow, pays a 2.48% dividend and controls valuable franchises. This trade idea lays out a mid-term (45 trading days) …
Zscaler has been sold off in a broader SaaS/AI rotation, but the company's market position in zero-trust, healthy free cash flow, and recent product/corporate moves create an asymmetric reward profile. This is a tactical long for the mid term (45 trading days) with a clear entry, stop, and target tied to fundamentals and technical oversold indicato…
FANUC's core factory automation and robot franchises are benefiting from reshoring, automotive electrification and a multi-year robotics upcycle. Technicals show price already above the 50-day and 20-day averages, and market sentiment is improving. We present a disciplined, actionable long with clear entry, stop and target, and a mid-term horizon t…
GSK punched through to a new 52-week high after a strong quarter, dividend lift and EU approval of Exdensur for severe asthma. Fundamentals and guidance point to steady 2026 growth while technical momentum supports a swing trade. Entry at $60.75 with a $67 target offers ~10% upside with a dividend yield buffer of ~2.84%.
Affirm (AFRM) has pulled back sharply from its moving averages and looks technically oversold while underlying free cash flow has jumped to $619M. Market cap is roughly $17.0B and the stock trades at a stretched P/E but at a improving cash conversion profile. This trade idea outlines a disciplined long entry, stop, and target for a mid-term swing (…
